Srebp-controlled glucose metabolism is essential for NK cell functional responses

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nature Immunology

• Publication date

  2017-09-18

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/ni.3838PMID 28920951
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Memory CD8+ T Cells Use Cell-Intrinsic Lipolysis to Support the Metabolic Programming Necessary for Development.

  2018cited by this paper
• Natural killer cell memory in infection, inflammation and cancer

  2016cited by this paper
• Weight and prognosis for influenza A(H1N1)pdm09 infection during the pandemic period between 2009 and 2011: a systematic review of observational studies with meta-analysis

  2016cited by this paper
• Metabolic regulation of immune responses: therapeutic opportunities.

  2016cited by this paper
• Memory CD8(+) T Cells Require Increased Concentrations of Acetate Induced by Stress for Optimal Function.

  2016cited by this paper
• Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells

  2016cited by this paper
• Targeting natural killer cells in cancer immunotherapy

  2016cited by this paper
• Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling.

  2015cited by this paper
• Global burden of cancer attributable to high body-mass index in 2012: a population-based study.

  2015cited by this paper
• Immunometabolism: Cellular Metabolism Turns Immune Regulator*

  2015cited by this paper
• Altered NK cell function in obese healthy humans

  2015cited by this paper
• NK cell function and receptor diversity in the context of HCV infection

  2015cited by this paper
• mTORC1-Dependent Metabolic Reprogramming Is a Prerequisite for NK Cell Effector Function

  2014cited by this paper
• mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity

  2014cited by this paper
• 25-Hydroxycholesterol acts as an amplifier of inflammatory signaling

  2014cited by this paper
• Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development.

  2014cited by this paper
• 25-Hydroxycholesterol suppresses interleukin-1–driven inflammation downstream of type I interferon

  2014cited by this paper
• Assessment of ionic liquid stationary phases for the GC analysis of fatty acid methyl esters

  2014cited by this paper
• De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells

  2014cited by this paper
• Cell-intrinsic lysosomal lipolysis is essential for macrophage alternative activation

  2014cited by this paper
• The sterol regulatory element binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity

  2013cited by this paper
• DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+ T and NK cells

  2013cited by this paper
• Subverting sterols: rerouting an oxysterol-signaling pathway to promote tumor growth

  2013cited by this paper
• Fueling Immunity: Insights into Metabolism and Lymphocyte Function

  2013cited by this paper
• On the role of 25-hydroxycholesterol synthesis by glioblastoma cell lines. Implications for chemotactic monocyte recruitment.

  2013cited by this paper
• Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation

  2012cited by this paper
• Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors

  2012cited by this paper
• Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: a possible compensatory mechanism.

  2012cited by this paper
• Connecting mTORC1 signaling to SREBP-1 activation

  2012cited by this paper
• IsoCor: correcting MS data in isotope labeling experiments

  2012cited by this paper
• Cytokine activation induces human memory-like NK cells.

  2012cited by this paper
• Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation.

  2011cited by this paper
• Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a.

  2011cited by this paper
• Metabolite extraction from adherently growing mammalian cells for metabolomics studies: optimization of harvesting and extraction protocols

  2011cited by this paper
• Natural Killer Cells in Obesity: Impaired Function and Increased Susceptibility to the Effects of Cigarette Smoke

  2010cited by this paper
• Identification of the Citrate-binding Site of Human ATP-Citrate Lyase Using X-ray Crystallography*

  2010cited by this paper
• Activation of a metabolic gene regulatory network downstream of mTOR complex 1.

  2010cited by this paper
• IκBζ is essential for natural killer cell activation in response to IL-12 and IL-18

  2010cited by this paper
• Are Natural Killer Cells Protecting the Metabolically Healthy Obese Patient?

  2009cited by this paper
• Cytokine-induced memory-like natural killer cells

  2009cited by this paper
• Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.

  2009cited by this paper
• The mitochondrial citrate carrier: Metabolic role and regulation of its activity and expression

  2009cited by this paper
• Human natural killer cells.

  2008cited by this paper
• Pharmacologic Inhibition of Site 1 Protease Activity Inhibits Sterol Regulatory Element-Binding Protein Processing and Reduces Lipogenic Enzyme Gene Expression and Lipid Synthesis in Cultured Cells and Experimental Animals

  2008cited by this paper
• Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Oxysterols block transport by binding to Insig

  2007cited by this paper
• Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues.

  2007cited by this paper
• Transcription of the mitochondrial citrate carrier gene: role of SREBP-1, upregulation by insulin and downregulation by PUFA.

  2007cited by this paper
• Sterol regulatory element-binding proteinsは肝臓のインスリン受容体基質-2を介したインスリンシグナルを抑制する

  2005cited by this paper
• A simplified and efficient method for the analysis of fatty acid methyl esters suitable for large clinical studies Published, JLR Papers in Press, August 1, 2005. DOI 10.1194/jlr.D500022-JLR200

  2005cited by this paper
• Histone hyperacetylated domains across the Ifng gene region in natural killer cells and T cells.

  2005cited by this paper
• Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes DOI 10.1194/jlr.M100417-JLR200

  2002cited by this paper
• SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.

  2002cited by this paper
• SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation.

  2001cited by this paper
• Plasma oxysterols and tocopherol in patients with diabetes mellitus and hyperlipidemia

  2000cited by this paper
• Transcriptional Regulation of the ATP Citrate-lyase Gene by Sterol Regulatory Element-binding Proteins*

  2000cited by this paper
• The Roles of Sterol Regulatory Element-binding Proteins in the Transactivation of the Rat ATP Citrate-Lyase Promoter*

  2000cited by this paper
• Sterol Regulatory Element-binding Protein-1 as a Key Transcription Factor for Nutritional Induction of Lipogenic Enzyme Genes*

  1999cited by this paper
• Nuclear Sterol Regulatory Element-binding Proteins Activate Genes Responsible for the Entire Program of Unsaturated Fatty Acid Biosynthesis in Transgenic Mouse Liver*

  1998cited by this paper
• A population based study

  1993cited by this paper

• Glutathione is critical for NK cell-mediated immunity.

  2026cites this paper
• Effects of Rapid Weight Loss on the Immune System in Combat Sports Athletes: A Systematic Review

  2026cites this paper
• Citrate clearance is a major function of aconitase 2 in the canonical TCA cycle.

  2026cites this paper
• Emerging potential of CAR-NK cell therapy for hepatocellular carcinoma: current advances and translational challenges

  2026cites this paper
• Alterations in NK Cell Function and Glucose Metabolism Characteristics in Patients With Progressive Hepatocellular Carcinoma.

  2026cites this paper
• Natural Killer and CAR-NK Cell Therapies in Urological Cancers: Progress, Mechanistic Lessons from CAR-T, and Future Directions.

  2026cites this paper
• Aspartate availability drives differential engagement of the malate-aspartate shuttle.

  2026cites this paper
• Natural killer cell exhaustion in ovarian cancer: from molecular suppression to therapeutic revival

  2026cites this paper
• The metabolic drivers of IFN-γ release: glycolysis and acetyl CoA ride in the front seat.

  2025cites this paper
• Tissue-Specific Metabolic Reprogramming in Innate Lymphoid Cells and Its Impact on Disease

  2025cites this paper
• Natural killer cells: the immune frontline against circulating tumor cells

  2025cites this paper
• Cytokines in Focus: IL-2 and IL-15 in NK Adoptive Cell Cancer Immunotherapy

  2025cites this paper
• ACLY promotes NK cell effector function by regulating glycolysis and histone acetylation

  2025cites this paper
• Inhibition of eEF-2K enhances the antitumor efficacy of NK cells.

  2025cites this paper
• Autofluorescence lifetime imaging classifies human B and NK cell activation state

  2025cites this paper
• Metabolism-driven posttranslational modifications and immune regulation: Emerging targets for immunotherapy

  2025cites this paper
• Impaired natural killer cell migration in HIV-infected individuals is caused by TIGIT-mediated inhibition of HIF-1α-dependent glycolysis

  2025cites this paper
• Chronic HBV infection impairs the glucose metabolism and effector function of NK cells via HBsAg/IL-15/mTOR axis

  2025cites this paper
• Lactate Metabolic Reprogramming Mediated by CircRNA–LDHA Complex Facilitates Innate Immune Evasion of Liver Cancer

  2025cites this paper
• Succinate in innate immunity: linking metabolic reprogramming to immune modulation

  2025cites this paper
• Host-related Determinants of Response to Immunotherapy in Non-small Cell Lung Cancer: The Interplay of Body Composition, Metabolism, Sex and Immune Regulation

  2025cites this paper
• Leptin, NK cells, and the weight of immunity: Insights into obesity.

  2025cites this paper
• Glycolytic diversity drives immune complexity in cancer.

  2025cites this paper
• Expression of metabolic genes in NK cells is associated with clinical outcomes in patients with severe COVID-19: a brief report

  2025cites this paper
• Unraveling the link between cholesterol and immune system in cancer: from biological mechanistic insights to clinical evidence. A narrative review.

  2025cites this paper
• Uptake of lipids from ascites drives NK cell metabolic dysfunction in ovarian cancer.

  2025cites this paper
• The role of immune cells glycolysis in neuroinflammation secondary to intracerebral hemorrhage.

  2025cites this paper
• Dysregulated glutathione metabolism impairs natural killer cell function in patients with acute leukemia.

  2025cites this paper
• Dietary lipid overload creates a suppressive environment that impedes the antiviral functions of NK cells

  2025cites this paper
• Powering immunity: mitochondrial dynamics in natural killer cells.

  2025cites this paper
• Natural killer cells in kidney immune surveillance, injury and fibrosis

  2025cites this paper
• Anti‐Tumor Strategies Targeting Nutritional Deprivation: Challenges and Opportunities

  2025cites this paper
• Species-specific serine metabolism differentially controls natural killer cell functions

  2025cites this paper
• Choline in immunity: a key regulator of immune cell activation and function

  2025cites this paper
• Natural Killer Cell‐Mediated Antitumor Immunity: Molecular Mechanisms and Clinical Applications

  2025cites this paper
• Polyamines in pancreatic cancer: reshaping the immunosuppressive tumor microenvironment.

  2025cites this paper
• Bempedoic acid attenuates vascular inflammation and oxidative stress in a preclinical model of abdominal aortic aneurysm.

  2025cites this paper
• The metabolism-immune axis in colorectal cancer: remodeling the tumor microenvironment through metabolite signaling

  2025cites this paper
• Phenotypes, mechanisms, and therapeutic strategies of natural killer cell immunosenescence

  2025cites this paper
• CPT2 inhibition enhances selective autophagy and proliferation in colorectal cancer via GPAT4-dependent glycerophospholipid biosynthesis

  2025cites this paper
• Glucose Metabolism Reprogramming of Immune Cells in the Microenvironment of Pancreatic and Hepatobiliary Cancers

  2025cites this paper
• Mitochondrial dynamics and metabolic attributes regulate function of natural killer cell and infiltration in tumor microenvironment modulating disease progression.

  2025cites this paper
• Natural killer loops: pyruvate in, lactate out

  2025cites this paper
• Pivotal role of exogenous pyruvate in human natural killer cell metabolism

  2025cites this paper
• Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies

  2025cites this paper
• Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy

  2025cites this paper
• Unlocking the power of innate lymphoid cell plasticity in the tumor microenvironment: A revolutionary pathway for cancer immunotherapy.

  2025cites this paper
• Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy

  2025cites this paper
• Metabolic Reprogramming of NK Cells Drives Anti-Tumor Immunity.

  2025cites this paper
• Glutaminase activity maintains NK cell cytotoxicity through metabolic regulation of effector function

  2025cites this paper
• Cholesterol metabolism in tumor immunity: Mechanisms and therapeutic opportunities for cancer.

  2025cites this paper
• Unraveling the complexities of diet induced obesity and glucolipid dysfunction in metabolic syndrome

  2025cites this paper
• Inhibition of ATP-citrate lyase by bempedoic acid protects against abdominal aortic aneurysm formation in mice.

  2025cites this paper
• Amino acid and cholesterol metabolism in innate immunity.

  2025cites this paper
• Unraveling the mystery of citrate transporters in Alzheimer's disease: An updated review.

  2025cites this paper
• Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy

  2024cites this paper
• Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential

  2024cites this paper
• Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment

  2024cites this paper
• Immmunometabolism of systemic lupus erythematosus.

  2024cites this paper
• NK cell profiling in West Nile virus encephalitis reveals potential metabolic basis for functional inhibition

  2024cites this paper
• Molecular Targets for Cannabinoids in Natural Killer Cells: Do They Modulate the Antitumor Activity?

  2024cites this paper
• Deciphering metabolic crosstalk in context: lessons from inflammatory diseases

  2024cites this paper
• Developing and validating the model of tumor-infiltrating immune cell to predict survival in patients receiving radiation therapy for head and neck squamous cell carcinoma

  2024cites this paper
• The multivisceral landscape of colorectal cancer metastasis: implications for targeted therapies

  2024cites this paper
• Nanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy.

  2024cites this paper
• Advanced nanomaterials for enhanced immunotherapy via metabolic regulation

  2024cites this paper
• Iron deficiency in people with obesity drives defective Natural Killer cell mitochondrial fitness and function

  2024cites this paper
• No time to die: Epigenetic regulation of natural killer cell survival

  2024cites this paper
• Breakthrough of solid tumor treatment: CAR-NK immunotherapy

  2024cites this paper
• Fatty acid metabolism: A new target for nasopharyngeal carcinoma therapy.

  2024cites this paper
• Targeting glutamine metabolism crosstalk with tumor immune response.

  2024cites this paper
• Approaches to investigate tissue-resident innate lymphocytes metabolism at the single-cell level

  2024cites this paper
• Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer

  2024influential citation
• Research Hotspots and Trends in Global Cancer immunometabolism:A Bibliometric Analysis from 2000 to 2023

  2024cites this paper
• Natural Killer Cell Dysfunction In Human Bladder Cancer Is Caused By Tissue-Specific Suppression of SLAMF6 Signaling

  2024cites this paper
• 127aa encoded by circSpdyA promotes FA synthesis and NK cell repression in breast cancers

  2024cites this paper
• Harnessing glucose metabolism with nanomedicine for cancer treatment

  2024cites this paper
• Metabolic heterogeneity in tumor microenvironment - A novel landmark for immunotherapy.

  2024cites this paper
• In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors

  2024cites this paper
• Pharmacological therapy targeting the immune response in atherosclerosis.

  2024cites this paper
• Metabolic requirements of CD160 expressing memory‐like NK cells in Gram‐negative bacterial infection

  2024cites this paper
• Immunometabolism in atherosclerotic disorders

  2024cites this paper
• Tubular insulin-induced gene 1 deficiency promotes NAD+ consumption and exacerbates kidney fibrosis

  2024cites this paper
• SREBP2 restricts osteoclast differentiation and activity by regulating IRF7 and limits inflammatory bone erosion

  2024cites this paper
• Metabolic programming of organ‐specific natural killer cell responses

  2024cites this paper
• Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer

  2024cites this paper
• The immunosuppressive landscape in tumor microenvironment

  2024cites this paper
• Importance of SREBP signaling in controlling lipid metabolism and homeostasis in B cells for future vaccine design

  2024cites this paper
• MEF2C regulates NK cell effector functions through control of lipid metabolism

  2024cites this paper
• Tuning Cellular Metabolism for Cancer Virotherapy.

  2024cites this paper
• Optimizing glutamine concentration enhances ex vivo expansion of natural killer cells through improved redox status

  2024cites this paper
• Non-Specific Elevated Serum Free Fatty Acids in Lung Cancer Patients: Nutritional or Pathological?

  2024cites this paper
• Natural killer cells at the forefront of cancer immunotherapy with immune potency, genetic engineering, and nanotechnology.

  2023cites this paper
• Single-cell deconvolution reveals high lineage- and location-dependent heterogeneity in mesenchymal multivisceral stage 4 colorectal cancer

  2023cites this paper
• Impact of apolipoprotein A1 on tumor immune microenvironment, clinical prognosis and genomic landscape in hepatocellular carcinoma

  2023cites this paper
• Fatty acids are crucial to fuel NK cells upon acute retrovirus infection

  2023cites this paper
• Natural killer cells and type 1 innate lymphoid cells in cancer.

  2023cites this paper
• Recent advancements in nanomedicine based lipid metabolism for tumour immunotherapy

  2023cites this paper
• Immunometabolism: a new dimension in immunotherapy resistance

  2023cites this paper
• The Characteristics of Natural Killer Cells and Prediction of Prognosis in Bladder Urothelial Carcinoma

  2023cites this paper